EGFR and lung adenocarcinoma: Anaplastic lymphoma kinase (ALK)-mutated or epidermal growth factor receptor (EGFR)-mutated lung adenocarcinoma patients with brain metastases are primarily treated with systemic molecular therapies instead of upfront brain irradiation, especially when there are few and small lesions in the CNS.